Approval · Notice of Compliance 3161 · 1998
EPIJECT I.V.: Notice of Compliance 3161
Issued July 15, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3161
- Date
- July 15, 1998
- Company
- Abbott Laboratories Co.Saint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anticonvulsant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EPIJECT I.V. | 02238368 | Cancelled Post Market |
Medicinal ingredients
- SODIUM VALPROATE 100 MG per ML